Primary Site >> Stomach Cancer
Gene >> FCGR3A
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Ref: Differential activation of lymphokine-activated killer cells with different surface phenotypes by cultivation with recombinant interleukin 2 or T-cell growth factor in gastric cancer patients. PMID: 2498249 |
Ref: [Immunohistochemical study using a double fluorescent staining on the regional lymph nodes of gastric cancers]. PMID: 1690346 Ref: [A clinical study of immunological status in gastric cancer patients--with special reference to T-cell subsets in the lymphocytes of regional lymph nodes]. PMID: 2263239 Ref: [Clinical application of adoptive immunotherapy by cytotoxic T lymphocytes induced from tumor-infiltrating lymphocytes]. PMID: 2391445 |
Ref: Epitope analysis of cluster 1 and NK cell-related monoclonal antibodies. PMID: 1710138 Ref: Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma. PMID: 1718596 Ref: Differential depression of lymphocyte subsets according to stage in stomach cancer. PMID: 2067132 |
Ref: Expression of intercellular adhesion molecule 1 (ICAM-1) during the development of invasion and/or metastasis of gastric carcinoma. PMID: 1355484 Ref: Defective autologous mixed lymphocyte reaction (AMLR) and killer activity generated in the AMLR in cancer patients. PMID: 1532952 Ref: In vitro generation of activated natural killer cells and cytotoxic macrophages with lentinan. PMID: 1623902 |
Ref: Study of effect of surgical stress on immunity in patients with gastrointestinal cancer. PMID: 8274052 Ref: [Immunological effects of locoregional immunochemotherapy for liver metastases of gastric cancer]. PMID: 8373205 |
Ref: Defective natural killer activity in gastric cancer patients: possible involvement of suppressor factor receptor. PMID: 7803704 Ref: Lymphokine-activated killer cell function of peripheral blood mononuclear cells, spleen cells and regional lymph node cells in gastric cancer patients. PMID: 8004819 Ref: Peripheral blood T cell subsets as a prognostic factor in gastric cancer. PMID: 8126923 Ref: Lymphokine-activated killer cell activity of peripheral blood, spleen, regional lymph node, and tumor infiltrating lymphocytes in gastric cancer patients. PMID: 8176929 |
Ref: Generation of lymphokine-activated killer (LAK) cell activity from malignant peritoneal effusions. PMID: 7624448 Ref: Peripheral blood lymphocyte subsets in patients with stomach cancer. PMID: 8527041 |
Ref: Carcinoma of the stomach following the Chernobyl nuclear accident. PMID: 9337683 |
Ref: Impact of splenectomy on circulating T-lymphocyte subsets in stage III gastric cancer. PMID: 12121160 |
Ref: [Correlation of the changes of T lymphocyte phenotype to tumor stage and operative pattern of gastric cancer]. PMID: 15363203 |
Ref: Sex differences in cytokine production and surface antigen expression of peripheral blood mononuclear cells after surgery. PMID: 16105533 |
Ref: [An assessment of peripheral blood lymphocytes populations and subpopulation in patients with stomach cancer]. PMID: 16617730 |
Ref: The importance of T-lymphocyte subsets on overall survival of colorectal and gastric cancer patients. PMID: 17768369 Ref: Contribution of dendritic cells' FcgammaRI and FcgammaRIII to cross-presentation of tumor cells opsonized with the anti-MHC class I monoclonal antibodies. PMID: 18087220 |
Ref: Neoadjuvant therapy of gastric cancer with the human monoclonal IgM antibody SC-1: impact on the immune system. PMID: 18288413 |
Ref: Immunonutritional diet modulates natural killer cell activation and Th17 cell distribution in patients with gastric and esophageal cancer. PMID: 21215924 Ref: [The epidemiological analysis of monitoring of the immune status in liquidators of consequences of the Chernobyl accident for early identification of risk groups and diagnostics of oncological diseases. Report 1]. PMID: 21520622 |
Ref: Quality of life, immunomodulation and safety of adjuvant mistletoe treatment in patients with gastric carcinoma - a randomized, controlled pilot study. PMID: 23033982 |
Ref: The extended leukocyte differential count using the Cytodiff flow cytometric system reveals that higher CD16+ cytotoxic NK+T lymphocyte levels predict superior survival outcomes in patients with metastatic carcinoma. PMID: 23281059 |
Ref: T lymphocytes expressing a CD16 signaling receptor exert antibody-dependent cancer cell killing. PMID: 24197131 Ref: Flurbiprofen improves dysfunction of T-lymphocyte subsets and natural killer cells in cancer patients receiving post-operative morphine analgesia. PMID: 24755130 Ref: Altered expression of hypoxia-inducible factor-1alpha (HIF-1alpha) and its regulatory genes in gastric cancer tissues. PMID: 24927122 Ref: Function and subsets of dendritic cells and natural killer cells were decreased in gastric cancer. PMID: 25550889 |
Ref: First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors. PMID: 28119295 |